Ester Industries (ESTER)

FairStock Score: 4/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding is high at 62.71%, aligning management with minority shareholders.
• Price-to-book of 1.10 is modest, with book value at ₹83.16 providing some asset backing.
• Sales decline is only 1.91%, showing demand base is not collapsing despite losses.
• Positive ROCE of 6.45% suggests some operating cash generation before financial costs.

Concerns

• Net loss in latest quarter of ₹12 Cr and profit growth of -150% show earnings deterioration.
• Piotroski F-Score of 3/9 indicates weak financial condition and possible operational distress.
• Debt-to-equity of 0.93 is high for a business earning sub-7% ROCE, increasing financial risk.
• No clear competitive moat in a commoditized packaging industry, limiting pricing power.

AI Analysis

This is not a business Buffett would admire. At ₹91.72, Ester Industries trades at 1.10 times book value of ₹83.16, but the P/E is meaningless because earnings are negative. The latest quarter tells the real story: ₹339 Cr of sales produced a net loss of ₹12 Cr. Profit growth has collapsed by 150%, and sales are falling at 1.91%. ROE is just 1.47% and ROCE 6.45% — both far below what I would demand from a packaging business with debt-to-equity of 0.93. The Piotroski score of 3/9 further confirms financial weakness. I see no moat here; packaging films and polymers are largely commoditised, with pricing power dictated by industry capacity and raw material costs. Promoter holding of 62.71% is a genuine positive — skin in the game matters — but aligned ownership cannot replace a weak business model. The 0.57% dividend yield is trivial compensation while the company burns cash at the operating level. Book value offers some theoretical floor, but paying a premium to that book for a loss-making, debt-laden business violates my margin-of-safety principle. This feels like a cyclical company caught in a downswing, or perhaps a value trap dressed in modest ratios. I need hard evidence of margin recovery, better capital allocation, and deleveraging before I would touch it. Until then, I would rather wait for a better business at a fair price than chase numbers that offer no real earnings support. Price is what you pay; value is what you get — and here, value is extremely uncertain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer